Protocol and intention-to-treat analyses were also taken into account as secondary outcome measures. Clinical conditions of patients were assessed at the time of prescription and one year after H. pylori eradication treatment. The assessment was based on the Rome III criteria for functional gastrointestinal disorders in adults.
Se evaluó al momento de la prescripción de la terapia y al año después del tratamiento de la erradicación para H. pylori la condición clínica de los pacientes, con base en los criterios de Roma III para los trastornos gastrointestinales funcionales del adulto.